Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Gregory Schwartz

Concepts (589)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Acute Coronary Syndrome
74
2025
297
15.830
 Why?
Anticholesteremic Agents
55
2026
155
12.540
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
57
2025
442
7.680
 Why?
Lipoprotein(a)
22
2025
69
7.400
 Why?
Antibodies, Monoclonal, Humanized
47
2025
994
6.370
 Why?
Cholesterol, LDL
53
2026
359
6.330
 Why?
Myocardial Infarction
45
2026
1216
4.760
 Why?
Cardiovascular Diseases
41
2026
2185
4.340
 Why?
Proprotein Convertase 9
29
2025
87
3.710
 Why?
Coronary Disease
16
2020
381
3.030
 Why?
Angina, Unstable
19
2019
83
2.730
 Why?
Heptanoic Acids
23
2016
67
2.580
 Why?
Cholesterol, HDL
13
2020
200
2.560
 Why?
Diabetes Mellitus, Type 2
23
2025
2582
2.510
 Why?
Sulfhydryl Compounds
10
2020
188
2.440
 Why?
Dyslipidemias
9
2025
184
2.430
 Why?
Hypercholesterolemia
11
2023
95
2.390
 Why?
Pyrroles
23
2016
213
2.370
 Why?
Stroke
32
2026
1272
2.240
 Why?
Quinazolinones
7
2021
19
2.090
 Why?
Serine Proteinase Inhibitors
6
2025
48
2.090
 Why?
Atherosclerosis
12
2026
410
1.580
 Why?
Myocardial Ischemia
17
2018
287
1.560
 Why?
Thiazolidinediones
10
2017
139
1.530
 Why?
Secondary Prevention
11
2019
256
1.510
 Why?
Double-Blind Method
43
2025
2060
1.500
 Why?
Cholesterol
12
2022
405
1.500
 Why?
Treatment Outcome
68
2026
11831
1.410
 Why?
Oxazoles
9
2022
48
1.350
 Why?
Esters
9
2020
72
1.340
 Why?
Amides
9
2020
99
1.320
 Why?
Thiophenes
9
2022
121
1.290
 Why?
Cholesterol Ester Transfer Proteins
5
2016
22
1.270
 Why?
Hypoglycemic Agents
18
2024
1392
1.220
 Why?
Risk Factors
45
2024
10874
1.210
 Why?
Aged
83
2026
26125
1.200
 Why?
Myocardial Contraction
14
2013
291
1.140
 Why?
Ventricular Fibrillation
3
2017
64
1.120
 Why?
Middle Aged
87
2026
36176
1.120
 Why?
Humans
176
2026
145491
1.120
 Why?
Swine
35
2023
833
1.090
 Why?
Coronary Artery Disease
6
2023
760
1.070
 Why?
C-Reactive Protein
11
2022
422
1.070
 Why?
Risk Assessment
21
2025
3759
1.070
 Why?
Insulin Resistance
10
2018
1244
1.050
 Why?
Antibodies, Monoclonal
7
2023
1511
1.000
 Why?
Myocardium
23
2004
932
1.000
 Why?
Diabetic Angiopathies
2
2019
263
0.990
 Why?
Metabolic Syndrome
4
2013
355
0.990
 Why?
Male
110
2026
72817
0.970
 Why?
Female
116
2026
78763
0.910
 Why?
Myocardial Reperfusion Injury
5
2013
139
0.910
 Why?
Ischemic Attack, Transient
6
2018
71
0.890
 Why?
Heart
10
2009
626
0.860
 Why?
Lipoproteins, HDL
4
2019
99
0.850
 Why?
PPAR gamma
6
2022
178
0.850
 Why?
Proteins
3
2020
1020
0.840
 Why?
RNA, Small Interfering
11
2026
632
0.830
 Why?
Hyperlipoproteinemia Type II
4
2026
32
0.820
 Why?
Proprotein Convertases
2
2014
16
0.810
 Why?
Peripheral Arterial Disease
3
2020
519
0.790
 Why?
Triglycerides
5
2024
518
0.770
 Why?
Biomarkers
24
2025
4283
0.770
 Why?
Fatty Acids, Nonesterified
4
2018
154
0.700
 Why?
Renal Insufficiency, Chronic
6
2026
663
0.690
 Why?
Randomized Controlled Trials as Topic
19
2024
1755
0.690
 Why?
Time Factors
22
2025
7171
0.680
 Why?
Patient Admission
2
2021
221
0.660
 Why?
Insulin
7
2021
2506
0.660
 Why?
Coronary Circulation
18
2004
136
0.660
 Why?
Cardiovascular Agents
4
2021
169
0.630
 Why?
Molecular Targeted Therapy
2
2014
439
0.630
 Why?
Hospitalization
5
2019
2458
0.610
 Why?
Recurrence
11
2021
1142
0.600
 Why?
Energy Metabolism
13
2004
932
0.570
 Why?
Adiponectin
2
2018
240
0.550
 Why?
Swine, Miniature
3
2013
89
0.550
 Why?
Lipid Metabolism
2
2014
529
0.530
 Why?
Venous Thrombosis
1
2020
194
0.530
 Why?
Brain Ischemia
5
2022
360
0.530
 Why?
Ezetimibe
4
2023
24
0.520
 Why?
Heart Arrest
4
2017
409
0.520
 Why?
Aldosterone
1
2017
42
0.500
 Why?
Rosuvastatin Calcium
4
2022
21
0.490
 Why?
Cardiovascular System
1
2018
137
0.490
 Why?
Venous Thromboembolism
1
2020
327
0.460
 Why?
Phospholipids
4
2025
216
0.440
 Why?
Arteriosclerosis
2
2014
83
0.440
 Why?
Patient Readmission
2
2021
769
0.430
 Why?
Drug Therapy, Combination
6
2020
1046
0.420
 Why?
Adenosine Triphosphate
14
2017
503
0.410
 Why?
Magnetic Resonance Spectroscopy
17
2019
625
0.390
 Why?
Metformin
1
2017
324
0.390
 Why?
Diabetes Complications
3
2021
223
0.390
 Why?
Apolipoproteins
4
2025
38
0.390
 Why?
Heart Failure
10
2026
2329
0.380
 Why?
Animals
49
2023
38141
0.380
 Why?
Phosphocreatine
13
1995
44
0.370
 Why?
Phosphates
7
2024
177
0.370
 Why?
Ventricular Function, Left
9
2004
539
0.360
 Why?
Hemodynamics
11
2007
1116
0.360
 Why?
Veterans
3
2023
1626
0.360
 Why?
Blood Pressure
11
2012
1782
0.360
 Why?
Proportional Hazards Models
9
2019
1332
0.350
 Why?
Coronary Vessels
8
2012
247
0.350
 Why?
Obesity
3
2024
3076
0.350
 Why?
Uncertainty
1
2012
147
0.340
 Why?
Dietary Fats
2
2013
308
0.340
 Why?
Atrial Fibrillation
2
2022
558
0.330
 Why?
Drug Administration Schedule
8
2019
782
0.330
 Why?
Glucose
5
2020
1039
0.320
 Why?
Follow-Up Studies
11
2023
5426
0.320
 Why?
Systole
7
2001
181
0.320
 Why?
Fluorobenzenes
2
2014
17
0.320
 Why?
Reperfusion Injury
2
2005
297
0.310
 Why?
Research Design
3
2009
1134
0.310
 Why?
Risk
9
2018
917
0.310
 Why?
Phospholipases A2, Secretory
4
2014
14
0.300
 Why?
Diastole
5
2001
146
0.290
 Why?
Ischemia
1
2012
430
0.280
 Why?
Ventricular Dysfunction, Right
3
2007
248
0.280
 Why?
Surgical Procedures, Operative
4
2017
272
0.270
 Why?
Apolipoproteins B
5
2022
47
0.270
 Why?
KATP Channels
1
2008
23
0.270
 Why?
Cohort Studies
6
2023
5992
0.260
 Why?
Clinical Trials, Phase III as Topic
3
2024
116
0.260
 Why?
Chromans
3
2004
23
0.260
 Why?
Acute Disease
9
2012
1040
0.260
 Why?
Peptide Fragments
4
2024
693
0.260
 Why?
Hypolipidemic Agents
3
2022
89
0.260
 Why?
Dose-Response Relationship, Drug
7
2019
2030
0.250
 Why?
Survival Analysis
7
2018
1374
0.250
 Why?
Mortality
3
2017
379
0.250
 Why?
Incidence
7
2022
2915
0.250
 Why?
Veterans Health
2
2020
189
0.250
 Why?
Apolipoprotein B-100
2
2025
13
0.250
 Why?
Potassium
2
2014
153
0.250
 Why?
Sodium
2
2020
198
0.250
 Why?
Cholecalciferol
1
2007
61
0.240
 Why?
Diet
3
2025
1280
0.240
 Why?
Pyrimidines
2
2014
520
0.240
 Why?
Prognosis
6
2024
4323
0.240
 Why?
Sulfonamides
2
2014
581
0.240
 Why?
Subtilisins
2
2023
9
0.230
 Why?
Hyperlipoproteinemia Type III
1
2025
4
0.230
 Why?
Fenofibrate
1
2005
28
0.230
 Why?
Endpoint Determination
1
2026
85
0.230
 Why?
Phenylurea Compounds
1
2026
119
0.230
 Why?
Dobutamine
5
2000
24
0.220
 Why?
Acetates
3
2019
81
0.220
 Why?
Adrenergic beta-Antagonists
3
2013
252
0.220
 Why?
Oxygen Consumption
8
2000
718
0.220
 Why?
Myelodysplastic Syndromes
1
2007
148
0.220
 Why?
Quinolines
1
2026
193
0.220
 Why?
Disease Models, Animal
8
2013
4559
0.210
 Why?
Apolipoprotein A-I
2
2018
39
0.210
 Why?
Cardiotonic Agents
3
2005
94
0.210
 Why?
Blood Glucose
6
2024
2330
0.210
 Why?
Natriuretic Peptide, Brain
3
2024
110
0.210
 Why?
Prediabetic State
2
2020
247
0.210
 Why?
Predictive Value of Tests
6
2025
2129
0.210
 Why?
Lanthanum
1
2024
13
0.210
 Why?
Morbidity
5
2017
322
0.210
 Why?
Hyperemia
3
1991
49
0.210
 Why?
Syndrome
6
2007
380
0.200
 Why?
Cause of Death
5
2017
469
0.200
 Why?
Injections, Subcutaneous
2
2024
170
0.200
 Why?
Phosphorylation
3
2013
1707
0.190
 Why?
Thiazoles
2
2003
139
0.190
 Why?
Isoproterenol
3
1998
96
0.190
 Why?
Serine Endopeptidases
2
2014
129
0.190
 Why?
Blood Vessels
1
2024
167
0.190
 Why?
Peroxisome Proliferator-Activated Receptors
4
2017
17
0.190
 Why?
Clinical Trials, Phase II as Topic
2
2019
76
0.190
 Why?
Genes, Bacterial
1
2023
170
0.180
 Why?
Residence Characteristics
3
2016
376
0.180
 Why?
Carcinoma, Hepatocellular
1
2026
372
0.180
 Why?
Calcitriol
2
2003
57
0.180
 Why?
Lipids
3
2024
709
0.180
 Why?
Multicenter Studies as Topic
3
2019
411
0.180
 Why?
Prostatic Neoplasms
5
2003
978
0.180
 Why?
Calcifediol
2
2000
31
0.180
 Why?
Livestock
2
2023
11
0.170
 Why?
Insulin Receptor Substrate Proteins
2
2013
55
0.170
 Why?
Receptors, Cytoplasmic and Nuclear
1
2003
207
0.170
 Why?
Diacetyl
1
2001
7
0.170
 Why?
PPAR alpha
4
2022
54
0.170
 Why?
Indoles
3
2019
508
0.170
 Why?
Propensity Score
2
2021
376
0.170
 Why?
Muscles
1
2022
332
0.170
 Why?
Cost-Benefit Analysis
2
2020
645
0.170
 Why?
Artificial Intelligence
1
2026
383
0.170
 Why?
Mental Status and Dementia Tests
1
2021
26
0.160
 Why?
Cytokines
2
2005
2054
0.160
 Why?
Oxidative Stress
2
2025
1350
0.160
 Why?
Pancreatic Neoplasms
2
2000
928
0.160
 Why?
Cataract
1
2023
212
0.160
 Why?
Myocardial Reperfusion
1
2000
57
0.160
 Why?
Glucagon-Like Peptide-1 Receptor
1
2020
88
0.150
 Why?
Calpain
2
2012
61
0.150
 Why?
Lipoproteins, LDL
2
2014
119
0.150
 Why?
Coronary Artery Bypass
2
2019
271
0.150
 Why?
Matrix Metalloproteinases
1
2000
95
0.150
 Why?
Cadmium
1
2000
68
0.150
 Why?
Liver Neoplasms
1
2026
779
0.150
 Why?
Non-alcoholic Fatty Liver Disease
1
2022
265
0.150
 Why?
Oncogenes
1
2000
118
0.150
 Why?
Perioperative Care
2
2017
232
0.150
 Why?
Renin-Angiotensin System
1
2019
80
0.140
 Why?
Proto-Oncogene Proteins c-akt
2
2013
436
0.140
 Why?
Alkaline Phosphatase
1
2019
144
0.140
 Why?
Aged, 80 and over
9
2026
8326
0.140
 Why?
Adrenergic beta-Agonists
1
1998
93
0.140
 Why?
Adenylyl Cyclases
2
2016
60
0.140
 Why?
Early Termination of Clinical Trials
2
2015
18
0.140
 Why?
Immunoturbidimetry
1
2018
1
0.140
 Why?
Multifactorial Inheritance
1
2019
190
0.140
 Why?
Carotid Artery Diseases
1
2018
70
0.140
 Why?
Risk Reduction Behavior
1
2020
217
0.140
 Why?
United States
7
2023
16115
0.140
 Why?
Collagen
1
2000
453
0.130
 Why?
American Heart Association
1
2019
360
0.130
 Why?
Environment
2
2016
307
0.130
 Why?
Citrate (si)-Synthase
1
2017
53
0.130
 Why?
Pharmacogenetics
2
2016
173
0.130
 Why?
Prostate
1
1998
158
0.130
 Why?
Microalgae
1
2016
10
0.130
 Why?
Ponds
1
2016
17
0.130
 Why?
Transcription Factors
2
2016
1733
0.120
 Why?
Hypertension, Pulmonary
3
2012
1957
0.120
 Why?
Australia
4
2019
289
0.120
 Why?
Administration, Intravenous
1
2017
171
0.120
 Why?
Waste Disposal, Fluid
1
2016
53
0.120
 Why?
HIV Long Terminal Repeat
1
2016
12
0.120
 Why?
Global Health
2
2017
404
0.120
 Why?
Drug Design
1
2017
176
0.120
 Why?
tat Gene Products, Human Immunodeficiency Virus
1
2016
25
0.120
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2026
1965
0.120
 Why?
Percutaneous Coronary Intervention
2
2019
559
0.120
 Why?
Inflammation Mediators
2
2013
505
0.120
 Why?
Simvastatin
2
2015
59
0.120
 Why?
HIV Envelope Protein gp120
1
2016
55
0.120
 Why?
Lipoproteins
2
2014
166
0.120
 Why?
Adult
15
2026
40707
0.120
 Why?
Signal Transduction
1
2009
5202
0.120
 Why?
Inflammation
6
2016
2883
0.120
 Why?
Epigenesis, Genetic
1
2021
672
0.120
 Why?
AMP-Activated Protein Kinases
1
2017
191
0.110
 Why?
Clinical Trials as Topic
2
2018
1058
0.110
 Why?
Heart Ventricles
6
2012
754
0.110
 Why?
Postoperative Complications
2
2019
2962
0.110
 Why?
Glomerular Filtration Rate
3
2026
765
0.110
 Why?
Anti-Arrhythmia Agents
2
2012
144
0.110
 Why?
ATP Binding Cassette Transporter 1
1
2015
13
0.110
 Why?
Platelet Aggregation Inhibitors
1
2019
505
0.110
 Why?
Vasodilation
2
2013
521
0.110
 Why?
Recombinant Proteins
1
2018
1367
0.110
 Why?
Chromosomes, Human, Pair 16
1
2015
35
0.110
 Why?
Smoking
2
2000
1468
0.110
 Why?
Hospital Mortality
1
2019
1044
0.110
 Why?
Wireless Technology
1
2014
18
0.110
 Why?
Bacteria
2
2023
897
0.110
 Why?
Linkage Disequilibrium
1
2015
249
0.100
 Why?
Homeostasis
1
2018
639
0.100
 Why?
Serum Amyloid A Protein
3
2013
32
0.100
 Why?
Transistors, Electronic
1
2014
7
0.100
 Why?
Stents
1
2018
570
0.100
 Why?
Seawater
1
2014
34
0.100
 Why?
Ions
1
2014
68
0.100
 Why?
Disease Progression
4
2018
2862
0.100
 Why?
Heart Rate
5
2001
859
0.100
 Why?
Fresh Water
1
2014
56
0.100
 Why?
Phospholipases A
1
2014
97
0.100
 Why?
Metals, Heavy
1
2014
32
0.100
 Why?
Fasting
1
2015
275
0.100
 Why?
Mendelian Randomization Analysis
1
2013
54
0.100
 Why?
Commerce
1
2014
80
0.100
 Why?
Endovascular Procedures
1
2018
400
0.100
 Why?
Acyl Coenzyme A
1
2013
32
0.100
 Why?
Heart Function Tests
1
2013
59
0.090
 Why?
Ultraviolet Rays
2
1992
384
0.090
 Why?
Hydroxy Acids
1
2012
4
0.090
 Why?
Ventricular Function, Right
1
1995
296
0.090
 Why?
Monitoring, Physiologic
1
2014
288
0.090
 Why?
Talin
1
2012
9
0.090
 Why?
Ischemic Preconditioning, Myocardial
1
2012
35
0.090
 Why?
Decanoic Acids
1
2012
12
0.090
 Why?
Glyburide
1
2012
31
0.090
 Why?
Cardiolipins
1
2013
83
0.090
 Why?
Nitric Oxide Synthase Type III
1
2013
203
0.090
 Why?
Potassium Channel Blockers
1
2012
47
0.090
 Why?
1-Alkyl-2-acetylglycerophosphocholine Esterase
1
2012
24
0.090
 Why?
North America
3
2019
312
0.090
 Why?
Polymorphism, Genetic
1
2015
616
0.090
 Why?
Biosensing Techniques
1
2014
140
0.090
 Why?
Case-Control Studies
1
2019
3619
0.090
 Why?
Europe
3
2019
421
0.090
 Why?
Retrospective Studies
6
2018
17269
0.090
 Why?
Keto Acids
3
2019
13
0.090
 Why?
Oxidation-Reduction
4
2025
1080
0.080
 Why?
DNA
2
2013
1451
0.080
 Why?
Practice Guidelines as Topic
1
2019
1585
0.080
 Why?
Hypertension
1
2000
1273
0.080
 Why?
Arteries
1
2013
261
0.080
 Why?
Prospective Studies
2
2021
8039
0.080
 Why?
Tissue Plasminogen Activator
2
2013
249
0.080
 Why?
Genetic Variation
1
2016
988
0.080
 Why?
MAP Kinase Signaling System
1
2013
306
0.080
 Why?
Fractures, Bone
1
2016
426
0.080
 Why?
Manure
2
2023
10
0.080
 Why?
Prejudice
1
2011
61
0.080
 Why?
Myocardial Revascularization
3
2017
85
0.080
 Why?
Death, Sudden, Cardiac
1
2012
231
0.080
 Why?
Electrocardiography
3
2011
669
0.080
 Why?
Phosphorus
5
1995
98
0.080
 Why?
Down-Regulation
2
2024
616
0.080
 Why?
HIV-1
1
2016
905
0.080
 Why?
Gene Expression Regulation
2
2013
2594
0.080
 Why?
United States Department of Veterans Affairs
3
2016
775
0.080
 Why?
Polymers
1
2014
494
0.080
 Why?
RNA, Messenger
3
2015
2820
0.070
 Why?
Age Factors
3
2011
3340
0.070
 Why?
MicroRNAs
1
2015
689
0.070
 Why?
Critical Care
1
2014
703
0.070
 Why?
Macrophages
1
2016
1509
0.070
 Why?
Vitamin D Deficiency
1
1990
190
0.070
 Why?
Vascular Diseases
2
2022
252
0.070
 Why?
Feeding Behavior
1
2014
694
0.070
 Why?
Ventricular Pressure
1
2007
52
0.070
 Why?
Neoplasms
1
2023
2897
0.070
 Why?
Diabetes Mellitus
1
2016
1076
0.070
 Why?
Equipment Design
3
2014
532
0.070
 Why?
Phosphatidylinositol 3-Kinases
1
2009
380
0.060
 Why?
Vitamin D
3
2000
403
0.060
 Why?
Models, Biological
1
2014
1815
0.060
 Why?
Angiomatosis
1
2006
5
0.060
 Why?
Ultrasonography, Interventional
2
2018
167
0.060
 Why?
Hemangioma, Capillary
1
2006
14
0.060
 Why?
Kaplan-Meier Estimate
2
2020
974
0.060
 Why?
Reactive Oxygen Species
1
2009
602
0.060
 Why?
Survival Rate
1
2011
2093
0.060
 Why?
Lactic Acid
2
1998
306
0.060
 Why?
Anti-Inflammatory Agents
1
2009
478
0.060
 Why?
Angina Pectoris
2
2004
75
0.060
 Why?
Ultrasonography
1
2009
784
0.060
 Why?
Apolipoproteins E
1
2025
94
0.060
 Why?
Cerebrovascular Disorders
2
2017
106
0.060
 Why?
Liver
2
2024
1895
0.050
 Why?
Chronic Disease
1
2011
1816
0.050
 Why?
alpha-Tocopherol
1
2004
32
0.050
 Why?
Sus scrofa
1
2004
64
0.050
 Why?
Pulse Wave Analysis
1
2025
267
0.050
 Why?
Linear Models
2
2013
848
0.050
 Why?
Vegetables
1
2025
162
0.050
 Why?
Heterozygote
1
2025
313
0.050
 Why?
Antigen-Antibody Complex
1
2004
70
0.050
 Why?
CD40 Ligand
1
2004
39
0.050
 Why?
Least-Squares Analysis
1
2004
74
0.050
 Why?
Arterial Occlusive Diseases
2
1982
95
0.050
 Why?
Administration, Oral
1
2007
863
0.050
 Why?
Economics, Pharmaceutical
1
2003
10
0.050
 Why?
Muscular Diseases
1
2004
108
0.050
 Why?
Ergocalciferols
1
2003
14
0.050
 Why?
Tumor Cells, Cultured
3
2003
883
0.050
 Why?
Radiation-Sensitizing Agents
1
2003
43
0.050
 Why?
Regional Blood Flow
3
1996
515
0.050
 Why?
Comorbidity
2
2019
1659
0.050
 Why?
Guidelines as Topic
1
2005
270
0.050
 Why?
Lactates
2
1994
83
0.050
 Why?
beta-Lactams
1
2023
32
0.050
 Why?
Death
2
2019
131
0.050
 Why?
Angiotensin Receptor Antagonists
1
2023
115
0.050
 Why?
Creatine Kinase
1
2022
72
0.040
 Why?
Pharmacogenomic Testing
1
2022
62
0.040
 Why?
Multivariate Analysis
2
2017
1544
0.040
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2023
229
0.040
 Why?
Drug Resistance, Bacterial
1
2023
206
0.040
 Why?
Verapamil
1
2001
37
0.040
 Why?
Precision Medicine
1
2025
456
0.040
 Why?
Organ Preservation Solutions
1
2001
46
0.040
 Why?
Receptors, Immunologic
1
2022
206
0.040
 Why?
Antioxidants
1
2004
549
0.040
 Why?
Controlled Clinical Trials as Topic
1
2000
27
0.040
 Why?
Goals
1
2022
185
0.040
 Why?
Ventricular Dysfunction
1
2000
16
0.040
 Why?
Myocardial Stunning
1
2000
4
0.040
 Why?
Tissue Inhibitor of Metalloproteinases
1
2000
16
0.040
 Why?
Collagenases
1
2000
22
0.040
 Why?
Hexamethonium
1
2000
5
0.040
 Why?
Vascular Stiffness
1
2025
486
0.040
 Why?
Liver Cirrhosis
1
2022
287
0.040
 Why?
Atropine
1
2000
37
0.040
 Why?
Dilatation, Pathologic
1
2000
61
0.040
 Why?
Arrhythmias, Cardiac
1
2003
355
0.040
 Why?
Soil Microbiology
1
2023
221
0.040
 Why?
Interleukin-6
3
2013
772
0.040
 Why?
Louisiana
1
2000
32
0.040
 Why?
Dipeptides
2
2012
56
0.040
 Why?
Health Care Costs
1
2003
427
0.040
 Why?
Cell Line
2
2016
2823
0.040
 Why?
Occupations
1
2000
50
0.040
 Why?
Matrix Metalloproteinase 9
1
2000
130
0.040
 Why?
Placebo Effect
1
2019
25
0.040
 Why?
Pericardium
1
2000
59
0.040
 Why?
Ventricular Dysfunction, Left
1
2003
394
0.040
 Why?
Pilot Projects
1
2025
1896
0.040
 Why?
Blood Chemical Analysis
1
2020
110
0.040
 Why?
Phospholipase A2 Inhibitors
1
2019
3
0.040
 Why?
New Zealand
1
2019
55
0.040
 Why?
Insulin Antagonists
1
1998
6
0.040
 Why?
Ventricular Function
1
1999
54
0.040
 Why?
Logistic Models
1
2004
2130
0.040
 Why?
Hormone Antagonists
1
1998
31
0.040
 Why?
Antigens, CD
1
2022
557
0.040
 Why?
Hungary
1
2018
4
0.040
 Why?
Placebos
1
2019
193
0.040
 Why?
Somatostatin
1
1998
53
0.040
 Why?
Israel
1
2018
46
0.040
 Why?
Infusion Pumps
1
2018
33
0.040
 Why?
Pulmonary Artery
2
2006
1127
0.040
 Why?
Microscopy, Electron
1
1999
413
0.040
 Why?
Netherlands
1
2018
82
0.040
 Why?
India
1
2019
220
0.040
 Why?
Drug Combinations
1
2000
397
0.030
 Why?
Elasticity
1
1999
191
0.030
 Why?
Sex Characteristics
1
2024
779
0.030
 Why?
Florida
1
1998
118
0.030
 Why?
Protective Factors
1
2018
99
0.030
 Why?
Drug Interactions
1
2019
404
0.030
 Why?
Algorithms
1
2026
1855
0.030
 Why?
Sex Factors
1
2024
2110
0.030
 Why?
Blood Flow Velocity
1
1999
420
0.030
 Why?
Drug Industry
1
2017
49
0.030
 Why?
Selection Bias
1
2017
38
0.030
 Why?
Catheterization
1
1997
185
0.030
 Why?
Poverty Areas
1
2016
43
0.030
 Why?
Drug Evaluation, Preclinical
1
2017
196
0.030
 Why?
Echocardiography, Transesophageal
1
1997
135
0.030
 Why?
Urban Health
1
2016
96
0.030
 Why?
Chi-Square Distribution
1
2017
529
0.030
 Why?
Erythrocytes
1
2022
751
0.030
 Why?
Pharmacogenomic Variants
1
2016
33
0.030
 Why?
Rural Health
1
2016
87
0.030
 Why?
Drug Discovery
1
2017
154
0.030
 Why?
Cardiac Catheterization
1
2000
570
0.030
 Why?
Internationality
1
2017
156
0.030
 Why?
Viral Tropism
1
2016
36
0.030
 Why?
Receptors, CCR5
1
2016
60
0.030
 Why?
Albuminuria
1
2017
190
0.030
 Why?
Receptors, CXCR4
1
2016
91
0.030
 Why?
CD4 Antigens
1
2016
137
0.030
 Why?
Troponin
2
2007
50
0.030
 Why?
Immunoglobulin M
2
2009
282
0.030
 Why?
Membrane Proteins
1
2022
1164
0.030
 Why?
Attitude of Health Personnel
1
2004
1188
0.030
 Why?
Genome-Wide Association Study
1
2022
1378
0.030
 Why?
Body Mass Index
1
2024
2425
0.030
 Why?
Fatty Acids
1
1998
459
0.030
 Why?
Myalgia
1
2015
13
0.030
 Why?
Angioplasty, Balloon, Coronary
1
1996
158
0.030
 Why?
Creatinine
1
2017
513
0.030
 Why?
Physicians
1
2004
952
0.030
 Why?
Receptors, LDL
1
2015
53
0.030
 Why?
Electromagnetic Radiation
1
2014
3
0.030
 Why?
Thrombolytic Therapy
1
1996
166
0.030
 Why?
Carotid Intima-Media Thickness
1
2015
75
0.030
 Why?
Cognitive Dysfunction
1
2021
470
0.030
 Why?
Social Class
1
2016
265
0.030
 Why?
Myositis
1
2015
57
0.030
 Why?
Lidocaine
1
1994
55
0.030
 Why?
Chemotherapy, Adjuvant
1
1996
427
0.030
 Why?
Quality of Life
1
2007
3195
0.030
 Why?
Hypertrophy, Left Ventricular
1
1995
123
0.030
 Why?
Fat Emulsions, Intravenous
1
1994
29
0.030
 Why?
Adenosine
2
1994
256
0.030
 Why?
Calibration
1
2014
154
0.030
 Why?
Analysis of Variance
1
2017
1304
0.030
 Why?
Electric Stimulation
1
1995
277
0.030
 Why?
Osmolar Concentration
1
1994
169
0.030
 Why?
ATP-Binding Cassette Transporters
1
2015
118
0.030
 Why?
Semiconductors
1
2014
32
0.030
 Why?
Seasons
1
2016
559
0.030
 Why?
Adenosine Diphosphate
1
1994
83
0.030
 Why?
Gene Expression Regulation, Neoplastic
1
2000
1439
0.030
 Why?
Stroke Volume
1
1997
654
0.030
 Why?
Pressure
1
2014
226
0.020
 Why?
Mice
3
2016
18338
0.020
 Why?
NAD
1
1994
82
0.020
 Why?
Solutions
1
2014
166
0.020
 Why?
Patient Outcome Assessment
1
2014
132
0.020
 Why?
Glycine
1
1994
186
0.020
 Why?
Mitochondria, Heart
1
1994
105
0.020
 Why?
Hyperglycemia
1
2017
376
0.020
 Why?
Perioperative Period
1
2013
70
0.020
 Why?
Vascular Cell Adhesion Molecule-1
1
2013
41
0.020
 Why?
Materials Testing
1
2014
348
0.020
 Why?
Binding Sites
1
2016
1313
0.020
 Why?
Heparin
1
1994
245
0.020
 Why?
Oxidative Phosphorylation
1
1994
209
0.020
 Why?
Dose-Response Relationship, Radiation
1
1992
140
0.020
 Why?
Immunoglobulin G
2
2009
890
0.020
 Why?
Nutrition Surveys
1
2014
280
0.020
 Why?
Actinin
1
2012
12
0.020
 Why?
Dogs
3
1984
438
0.020
 Why?
Socioeconomic Factors
1
2016
1327
0.020
 Why?
Weight Gain
1
2016
557
0.020
 Why?
Anti-Bacterial Agents
1
2023
1953
0.020
 Why?
Mathematics
1
1992
100
0.020
 Why?
Cardiomyopathy, Dilated
2
1992
356
0.020
 Why?
Cardiac Output, Low
1
1992
53
0.020
 Why?
South Africa
1
2013
266
0.020
 Why?
Electrophoresis, Polyacrylamide Gel
1
2012
325
0.020
 Why?
Vascular Resistance
2
1984
369
0.020
 Why?
Patient Selection
1
1996
742
0.020
 Why?
Biopsy
1
1995
1081
0.020
 Why?
Reperfusion
1
1991
54
0.020
 Why?
Perfusion
1
1992
249
0.020
 Why?
Disease-Free Survival
1
2013
771
0.020
 Why?
Georgia
1
2011
79
0.020
 Why?
Poisson Distribution
1
2011
78
0.020
 Why?
Constriction
1
1990
46
0.020
 Why?
Vitamin D-Binding Protein
1
1990
16
0.020
 Why?
Cross-Sectional Studies
2
2014
5891
0.020
 Why?
Cells, Cultured
1
1998
4127
0.020
 Why?
Anticoagulants
1
1996
750
0.020
 Why?
Regression Analysis
1
1992
1001
0.020
 Why?
Patient Discharge
1
2017
992
0.020
 Why?
Alleles
1
2013
893
0.020
 Why?
Cell Division
2
2003
753
0.020
 Why?
Hypoglycemia
1
2015
479
0.020
 Why?
Cognition Disorders
1
2014
541
0.020
 Why?
Autoantibodies
2
2009
1512
0.020
 Why?
Polymorphism, Single Nucleotide
1
2016
2146
0.020
 Why?
Fibrin Fibrinogen Degradation Products
1
2009
92
0.020
 Why?
Educational Status
1
2011
465
0.020
 Why?
Young Adult
2
2016
14192
0.020
 Why?
Thromboembolism
1
2009
128
0.020
 Why?
Environmental Exposure
1
1992
577
0.020
 Why?
Spectrin
1
2007
14
0.020
 Why?
Desmin
1
2007
24
0.020
 Why?
Densitometry
1
2007
35
0.020
 Why?
Sarcoplasmic Reticulum Calcium-Transporting ATPases
1
2007
32
0.020
 Why?
Databases, Factual
1
2013
1500
0.020
 Why?
Poverty
1
2011
525
0.020
 Why?
Heart Diseases
1
1990
342
0.020
 Why?
Calcium-Binding Proteins
1
2007
222
0.010
 Why?
Kidney
1
2014
1498
0.010
 Why?
ROC Curve
1
2007
619
0.010
 Why?
Fatal Outcome
1
2006
306
0.010
 Why?
Protein Processing, Post-Translational
1
2007
468
0.010
 Why?
Aminophylline
1
1984
12
0.010
 Why?
Vasomotor System
1
1984
46
0.010
 Why?
Solubility
1
2004
237
0.010
 Why?
Mice, Inbred C57BL
1
2014
5989
0.010
 Why?
Radiation, Ionizing
1
2003
86
0.010
 Why?
DNA, Neoplasm
1
2003
158
0.010
 Why?
Health Care Surveys
1
2004
538
0.010
 Why?
Immunohistochemistry
1
2006
1710
0.010
 Why?
Odds Ratio
1
2004
1082
0.010
 Why?
Electrophysiology
1
1982
218
0.010
 Why?
Echocardiography
2
1997
648
0.010
 Why?
Blotting, Western
1
2003
1162
0.010
 Why?
Vascular Surgical Procedures
1
2004
348
0.010
 Why?
Mixed Function Oxygenases
1
2000
49
0.010
 Why?
Chemoprevention
1
2000
92
0.010
 Why?
Hydrogen-Ion Concentration
2
1991
563
0.010
 Why?
Adolescent
2
2016
22485
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2000
975
0.010
 Why?
Thorax
1
1997
51
0.010
 Why?
Phosphorus Isotopes
1
1995
8
0.010
 Why?
Infusions, Parenteral
1
1994
47
0.010
 Why?
Apoptosis
1
2003
2411
0.010
 Why?
Cardiac Pacing, Artificial
1
1995
84
0.010
 Why?
Basal Metabolism
1
1994
59
0.010
 Why?
Substrate Specificity
1
1995
396
0.010
 Why?
T-Lymphocytes
1
2002
1996
0.010
 Why?
Glycolysis
1
1995
342
0.010
 Why?
Lung
1
2006
4103
0.010
 Why?
Stimulation, Chemical
1
1992
52
0.010
 Why?
Rats, Sprague-Dawley
1
1997
2526
0.010
 Why?
Diphosphoglyceric Acids
1
1991
3
0.010
 Why?
2,3-Diphosphoglycerate
1
1991
32
0.010
 Why?
Radio Waves
1
1991
28
0.010
 Why?
Rats
1
1997
5581
0.000
 Why?
Cardiomegaly
1
1990
174
0.000
 Why?
Theophylline
1
1984
41
0.000
 Why?
Heart Block
1
1984
41
0.000
 Why?
Oxygen
1
1984
986
0.000
 Why?
Magnetic Resonance Imaging
1
1990
3897
0.000
 Why?
Schwartz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (589) concept(s)
_
Co-Authors Expand Description
See all (25) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)